.avif)
Hikma Pharmaceuticals Email Format
Pharmaceutical Manufacturing
・
5,001-10,000 employees
・
London, England, UK
Hikma Pharmaceuticals is a multinational pharmaceutical company that develops, manufactures, and markets generic, specialty, and branded medicines across North America, MENA, and Europe.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@hikma.com
Company Overview
Industry
Pharmaceutical Manufacturing
Founded
1978
Headquarters
London, England, UK
Revenue
$2.5B-$5B
FUNDING Stage
Public
Website
Key Executives
Said Darwazah (Chief Executive Officer), Areb Kurdi (Acting CFO), Trish Bousfield (Chief Information Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Hikma Pharmaceuticals?
Hikma Pharmaceuticals uses the firstinitiallast format, so Jane Smith would be jsmith@hikma.com.
What are the three business segments that Hikma Pharmaceuticals operates across?
Hikma Pharmaceuticals operates across three segments: Injectables, Branded, and Hikma Rx. Injectables covers North America, MENA, and Europe, Branded focuses on the MENA region across 17 markets, and Hikma Rx serves the North American retail market with manufacturing in Columbus, Ohio.
How many people work at Hikma Pharmaceuticals?
Hikma Pharmaceuticals employs around 10,491 people globally, spanning its operations across the US, MENA region, Europe, and beyond. Tools like Clay can help you find and verify individual contacts within the company for outreach purposes.
Where does Hikma Pharmaceuticals' Branded segment generate most of its revenue?
Hikma Pharmaceuticals' Branded segment generates the bulk of its revenue in the MENA region, with Saudi Arabia, Algeria, and Egypt among its top markets. The segment includes branded generics and in-licensed patented products sold across 17 MENA markets.
Who leads Hikma Pharmaceuticals as CEO in 2026?
Said Darwazah serves as Chief Executive Officer of Hikma Pharmaceuticals in 2026. Other key executives include Areb Kurdi as Acting CFO and Trish Bousfield as Chief Information Officer.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating